Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Invest / LTD -- Ignore unavailable to you. Want to Upgrade?

To: Thean who wrote (7995)	3/30/1999 3:41:00 PM
From: Broken_Clock	Read Replies (1) \| Respond to of 14427

Thean, i sold my MU puts for in excess of a double and rolled them into sch leap puts. I was able to get a double amount of scwabs at a much higher strike. sch trailing pe is 117.

To: Thean who wrote (7995)	3/30/1999 5:09:00 PM
From: bw	Respond to of 14427

Thean..Thanks for the insights. I hope you're wrong about the $8 gap, but if I'm a long-termer on this one it shouldn't matter. As for the disadvantage of not having a sales team already in place, the following from the release today at least affirms that Cardinal does have a good group to manage the marketing: <Duramed and Cardinal noted that Cardinal MarketFORCE's management team has built a number of contract sales forces in the past, ranging in size from 25 to 400 people. The Cardinal team includes: * Don Wetherhold, president, with extensive experience in hormone replacement sales and marketing and two years with the second largest contract sales and marketing organization in the world. * Thomas Dimke, vice president of operations, one of two individuals who organized the U.S. roll-out of the largest contract sales and marketing organization in the world, and also spent 12 years at Ciba-Geigy in a variety of capacities, including executive regional director of sales, working in the women's health and hormone replacement areas. * Bruce Ward, vice president of sales, who was with the Ross Division of Abbott Laboratories for 14 years, which marketed a variety of products to obstetricians and gynecologists.>